Consistent with our in vitro results, the depletion of CEBPB in transplanted glioma cells not only significantly reduced the overall TAMs (Iba1 positive) content but also markedly decreased the content of CD206 or CD163 positive M2 TAMs (Figure 6B-E). The gene discussed is MRC1; the disease is central nervous system cancer.